Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube

The Official Journal Of The International Society For Pharmacoeconomics And Outcomes Research

Articles in Press

Value in Health offers readers the opportunity to access complete articles (Articles in Press) to be published in upcoming issues of Value in Health. Current Articles in Press can be found at: www.valueinhealthjournal.com, by clicking the “Articles in Press" tab.

Articles that appear in Articles in Press can be found in future issues of Value in Health listed below.  All articles in these future issues have been accepted for publication, and currently may be at any stage in the post-acceptance process, which include copy-editing, typesetting, author review, revisions, and pre-electronic production, with articles in earlier issues appearing sooner than articles in later issues. These accepted articles appear in Articles in Press only after completing the post-acceptance process and remain for viewing until approximately one month prior the hard copy release date (Note: The timeframe from when an article is accepted, and appears and remains in Articles in Press are approximate, pending submission to publisher, extent of typesetting, author turn-around times, revisions, etc. Thus, some accepted articles that appear below may not appear in Articles in Press).

Future Issues:

Value in Health 2014 Volume 18 Issue 2

COMMENTARIES

Using Big Data in Health Care – Statistical Caution When Using Big Data – Linking Medical Records and Health Care Transactions
William H. Crown, PhD

Developing a Measure of Value in Health Care
J. Matthew Austin, PhD; K.H. Ken Lee; Peter Pronovost

ISPOR TASK FORCE REPORTS

Marshal TFR Part 2

Ramsey TFR

ECONOMIC EVALUATION

Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active Rheumatoid Arthritis
Josh J Carlson, PhD; Sarika Ogale, PhD; Fred Dejonckheere, MD; Sean D Sullivan, PhD

Strengthening tuberculosis control overseas: Who benefits?
Hoa-Thi-Minh Nguyen, Ph.D; Roslyn I Hickson, Ph.D; Tom Kompas, Ph.D; Geoffry N Mercer, Ph.D; Kamalini M Lokuge, Ph.D

Comparing the cost-effectiveness of rituximab maintenance and radio-immunotherapy consolidation versus observation following first-line therapy in follicular lymphoma patients
Qiushi Chen; Turgay Ayer; Adam C Rose; Loretta J Nastoupil; Christopher R Flowers

Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment Value in Health
Rajeev Ayyagari, Wenhui Wei  , David Cheng  , BA, Chunshen Pan  , PhD, MSc, James Signorovitch  , PhD, Eric Wu

PATIENT-REPORTED OUTCOMES

Predictors of self-reported adherence to antihypertensive medicines: A multi-national, cross sectional survey
Valerie L Morrison, MA PhD CPsychol; Emily A Holmes, BA(hons) MSc; Sahdia Parveen, PhD; Catrin O Plumpton, MMath MSc PhD; Wendy Clyne; Sabina De Geest; Fabienne Dobbels; Bernard Vrijens; Przemyslaw Kardas; Dyfrig A Hughes, BPharm PhD MRPharmS FLSW FBPharmacolS

PREFERENCE-BASED ASSESSMENTS

Learning and Satisficing: An Analysis of Sequence Effects in Health Valuation Benjamin Matthew Craig, Ph.D.; Shannon K Runge, MA; Kim Rand-Hendriksen, PhD;
Juan M Ramos-Goni, BSc; Mark Oppe, PhD

Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment
Jeroen Luyten; Roselinde Kessels; Peter Goos; Philippe Beutels

COMPARATIVE EFFECTIVENESS RESEARCH / HTA

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials
Shannon Cope, MSc, Andreas Clemens, MD, Florence Hammès, PharmD, Herbert Noack, PhD, Jeroen P Jansen, PhD

A unified framework for classification of methods for benefit-risk assessment
Mehdi Najafzadeh, Ph.D.; Sebastian Schneeweiss, M.D.; Ph.D.; Niteesh K Choudhry, M.D.; Ph.D.; Katsiaryna Bykov, Pharm.D.; M.S.; Kristijan H Kahler, R.Ph.; Ph.D.; Diane P Martin, Ph.D.; Joshua J Gagne, Pharm.D.; Sc.D

Application of multi-category exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research
Datalink Ayad Ali; Almut Winterstein; Leslie Hendeles; Xiaomin Lu; Richard Segal; Abraham G Hartzema

The Changing Face of the Cost-Utility Literature, 1990-2012
Peter J Neumann; Teja Thorat; Jennifer Shi; Cayla Saret; Joshua Cohen

HEALTH POLICY ANALYSIS

Fairness versus Efficiency of Vaccine Allocation Strategies
Ming Yi, Ph.D.; Achla Marathe, Ph.D

Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013
Mata Charokopou, PharmD, MSc.; Istvan M Majer, PhD; Stefan Broekhuizen, BSc.; Johan B de Raad, PharmD, MSc.; Maarten Postma, PhD, Professor; Bart Heeg, MSc

METHODOLOGICAL ARTICLES

Implications of the minimal clinically important difference for health-related quality of life outcomes: a comparison of sample size requirements for an incontinence treatment trial
Alex Halme; Xavier Fritel; Andrea Benedetti; Ken Eng; Cara senbaum

Mapping the clinical Chronic Obstructive Pulmonary Disease questionnaire (CCQ) onto generic preference-based EQ-5D values
Melinde Rosanne Sorayah Boland, Msc; Job F Boven, Msc; Janwillem W Kocks, PhD GP; Thys Van der Molen, Prof, GP, PhD; Lucas M Goossens, PhD; Niels H Chavannes, MD GP; Maureen P Rutten-van Mölken, Prof. PhD

SYSTEMATIC REVIEWS

Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-world Evidence
Yue Zhong, M.D., Ph.D.; Pei-Jung Lin, Ph.D.; Joshua Cohen, Ph.D.; Aaron Winn, M.P.P. ; Peter Neumann, Sc.D

A systematic review of generic multidimensional Patient Reported Outcome Measures for children part I: descriptive characteristics
Astrid Janssens; Jo Thompson-Coon, PhD; Morwenna Rogers; Karen Allen; Colin Green, Professor; Crispin Jenkinson; Alan Tennant; Stuart Logan; Christopher Morris

A systematic review of generic multidimensional Patient Reported Outcome Measures for children part II: evaluation of psychometric performance of English language versions in a general population
Astrid Janssens; Jo Thompson-Coon, PhD; Morwenna Rogers; Karen Allen; Colin Green, Professor; Crispin Jenkinson; Alan Tennant; Stuart Logan; Christopher Morris

POLICY PERSPECTIVES

Need for multi-criteria evaluation of generic drug policies
Zoltan Kalo, MD MSc PhD; Anke-Peggy Holtorf, PhD MBA ; Rafael Alfonso-Cristancho, MD MSc PhD; Jie Shen, MSc MBA ; Tamás Ágh, MD MSc PhD; András Inotai, PharmD PhD ; Diana Brixner, PhD RPh

LETTER TO THE EDITOR

L. GARATTINI; Alessandro Curto; Katelijne van de Vooren

ERRATUM

Also in this issue, a Letter to the Editor on Current Performance-Based Schemes in Italy.


Value in Health Main Page

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2015 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.